ALC

#375
Alcon Inc. Ordinary Shares
80.34 USD
+0.71%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
80.06
80.35
Jahresspanne
71.55
99.20
Tagesänderung
+0.71%
Monatliche Änderung
+3.88%
6 month change
+8.39%
Jahresänderung
-12.55%
Vorheriger Schlusskurs
79.77
Eröffnung
80.23
Bid
Ask
Tief
80.06
High
80.35
Volumen
168
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 39.16 B
  • Employee 26 K
  • Founded N/A
  • CEO David J. Endicott
  • Website www.alcon.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente

Alcon Inc

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

Nachrichten